November 22, 2013

A key interpretation of the Compounding Quality Act (CQA) passed by Congress this week indicates that the ability of doctors to compound for office use in advance of an individual patient prescription is safe from federal interference. This practice, commonly referred to as office use, is a critical tool in the ability of doctors to care for their patients. The CQA itself is silent on the practice, leaving states, doctors, and patients concerned about its continued existence.

To read the full Alert click here.